surmount-1 tirzepatide trial obesity without diabetes A 72-week trial compared the two leading GLP-1 medications in adults with obesity (no diabetes). SURMOUNT-5: Tirzepatide shows superior weight
Pay in 4 interest-free payments of $5.31 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8





























